Insight Molecular Diagnostics
(NASDAQ) IMDX
Insight Molecular Diagnostics Financials at a Glance
Market Cap
$164.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$1.95M
Net Income (TTM)
-$47.84M
EPS (TTM)
-$1.48
P/E Ratio
-3.43
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$5.04
Volume
8,412
Open
$5.19
Price
$5.04
Volume
8,412
Open
$5.19
Previous Close
$5.04
Daily Range
$4.81 - $5.19
52-Week Range
$2.33 - $8.51
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$5.04
Volume
8,412
Open
$5.19
Previous Close
$5.04
Daily Range
$4.81 - $5.19
52-Week Range
$2.33 - $8.51
Estimated Earnings Date
Aug 10, 2026
IMDX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Insight Molecular Diagnostics
Industry
Biotechnology
Sector
Health CareEmployees
58
CEO
Joshua Riggs
Website
www.oncocyte.comHeadquarters
Nashville, TN 92618, US
IMDX Financials
Key Financial Metrics (TTM)
Gross Margin
19.47%
Operating Margin
-2112.42%
Net Income Margin
-2454.64%
Return on Equity
380.80%
Return on Capital
N/A
Return on Assets
-118.34%
Earnings Yield
-29.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$164.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
32.29M
Volume
8.41K
Avg. Volume
357.72K
Financials (TTM)
Gross Profit
$379.50K
Operating Income
-$41.17M
EBITDA
-$45.40M
Operating Cash Flow
-$23.97M
Capital Expenditure
-$3.49M
Free Cash Flow
-$27.46M
Cash & ST Invst.
$28.20M
Total Debt
$3.07M
Insight Molecular Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$32.00K
-98.5%
Gross Profit
-$605.50K
-145.7%
Gross Margin
-18.92%
N/A
Market Cap
$164.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.83M
N/A
Employees
58
N/A
Net Income
-$4.29M
+35.7%
EBITDA
-$3.64M
+40.9%
Quarterly Fundamentals
Total Cash
$28.20M
-9.1%
Total Debt
$3.07M
-11.8%
Accounts Receivable
$157.00K
-95.6%
Inventory
$382.00K
-16.8%
Long Term Debt
$1.31M
-37.0%
Short Term Debt
$1.76M
+25.5%
Return on Assets
-1.18%
N/A
Return on Invested Capital
-1.45%
N/A
Free Cash Flow
-$8.25M
-33.9%
Operating Cash Flow
-$7.64M
-30.4%